These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 748092)

  • 1. Effect of exogenously administered glucagon on plasma glucose levels in totally depancreatized dogs.
    Nishimura I; Sudo T; Konishi K; Suzuki T; Tobe T; Nakagawa M; Nakase A
    Gastroenterol Jpn; 1978; 13(6):468-79. PubMed ID: 748092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
    Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
    Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of insulin and glucagon in regulating glucose turnover in dogs during exercise.
    Vranic M; Kawamori R; Wrenshall GA
    Med Sci Sports; 1975; 7(1):27-33. PubMed ID: 1143049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of glucagon reacting to 30 K antibody in totally depancreatized dogs.
    Sudo T; Konishi K; Nakase A; Suzuki T; Nishimura I; Tobe T
    Gastroenterol Jpn; 1978; 13(2):119-26. PubMed ID: 669196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased dependence of glucose production on peripheral insulin in diabetic depancreatized dogs.
    Giacca A; McCall R; Chan B; Shi ZQ
    Metabolism; 1999 Feb; 48(2):153-60. PubMed ID: 10024074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hypophysectomy and hypophysis-transplantation on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in depancreatized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):77-81. PubMed ID: 6248336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of glucagon administration on blood glucose level in totally depancreatized dogs (author's transl)].
    Nishimura I
    Nihon Geka Hokan; 1976 Sep; 45(5):390-7. PubMed ID: 1033741
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of gastrointestinal glucagon response to hypoglycaemia in depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Nonaka K; Tarui S
    Diabetologia; 1978 Dec; 15(6):471-4. PubMed ID: 720780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats.
    Dunbar JC; Walsh MF; Foà PP
    Diabetologia; 1978 Jan; 14(1):53-8. PubMed ID: 627333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of extrapancreatic glucagon to glycemic changes.
    Ohneda A; Kobayashi T; Nihei J
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():121-6. PubMed ID: 7014202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.
    Valverde I; Dobbs R; Unger RH
    Metabolism; 1975 Sep; 24(9):1021-8. PubMed ID: 1152674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dynamic property of glucagon secretion in response to blood glucose--analysis with the aid of the control theory using an artificial endocrine pancreas].
    Yagi T
    Nihon Naibunpi Gakkai Zasshi; 1985 Feb; 61(2):69-79. PubMed ID: 3891432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on glucose turnover and amino acid metabolism after total pancreatectomy].
    Mishina T
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):568-75. PubMed ID: 3043166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.